Colchicine for coronary artery disease

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 3 trial. Large late-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 23 Oct 2023: Trial registered, NCT06095765
  2. 29 Jan 2024: Trial started, NCT06095765

The trials

NCT06095765: Colchicine in Belgium in Patients With Coronary Artery Disease After Percutaneous Coronary Intervention

State
Under way
Phase
Phase 3
People
2,770 planned
Started
29 Jan 2024
Primary completion
1 Nov 2027
Arms
Colchicine
Results
None posted
  1. 23 Oct 2023: Trial registered
  2. 29 Jan 2024: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 3 trial

About the treatment

Kind of treatment: Drug.

Also known as Colcrys, Colchicine 0.6 mg, Colchicine 1 MG Oral Tablet, Colchicine Tablets, Colchicine only, Gloperba, Lodoco, Mitigare component colchicine, Myinfla.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.